Synthesis and Mechanism of p53-MDM2 Inhibitors with Heterocyclic Structures: A Focused Review

被引：0

作者：

Ji, Li-Tao ^{[1
]}

Zhang, Wenjing ^{[1
]}

Zhang, Yi ^{[1
]}

Zhao, Su ^{[1
]}

Long, Hai-Tao ^{[1
]}

Qin, Li-Qing ^{[1
]}

Tian, Jia-Cheng ^{[1
]}

Li, Hong-Zhang ^{[1
]}

Zhu, Dan-Xue ^{[1
]}

Zhou, Yan ^{[1
]}

Lu, Yi-Duo ^{[1
]}

Wang, Zhen-Chao ^{[1
,2
,3
]}

Li, Cheng-Peng ^{[1
,2
,3
]}

机构：

[1] Guizhou Univ, Coll Pharm, Guiyang 550025, Guizhou, Peoples R China

[2] Minist Educ, State Key Lab Breeding Base Green Pesticide & Agr, Key Lab Green Pesticide & Agr Bioengn, Guiyang 550025, Peoples R China

[3] Guizhou Univ, Guizhou Engn Lab Synthet Drugs, Guiyang 550025, Peoples R China

来源：

CHEMISTRYSELECT | 2023年 / 8卷 / 45期

关键词：

Small molecule; heterocyclic compounds; p53-MDM2; cancer; synthesis method; SMALL-MOLECULE INHIBITORS; PROTEIN-PROTEIN INTERACTION; STRUCTURE-BASED DESIGN; BIOLOGICAL EVALUATION; MDM2; INHIBITORS; SPIRO-OXINDOLES; CLINICAL-TRIALS; P53; PATHWAY; POTENT; DISCOVERY;

D O I：

10.1002/slct.202302240

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

P53 gene mutation is one of the important causes in tumors. p53-MDM2 (murine double minute 2) inhibitors can interrupt p53-dependent gene transcription activity, and inhibit p53-mediated apoptosis, block p53-MDM2/MDMx interaction, and significantly reduce DNA formation. In this article, we focused on the synthesis methods about nutlins and other p53 small molecule inhibitors, in order to find potential new structure for novel p53 small molecule inhibitor synthesizing. Mutation of the p53 gene is among the most important causes of tumors. Inhibitors of p53-MDM2 can impede p53-dependent gene transcription, inhibit p53-mediated apoptosis, block p53-MDM2/MDMx interaction, and significantly reduce DNA formation. In this review we discuss the synthesis of nutlins and other small-molecule p53 inhibitors, with an aim to inspire new structures and methods for the synthesis of future small-molecule p53 inhibitors.+image

引用

页数：16

共 50 条

[41] Explaining oscillations and variability in the p53-Mdm2 system
Proctor, Carole J.
Gray, Douglas A.
BMC SYSTEMS BIOLOGY, 2008, 2
[42] Recent Advances of p53-MDM2 Small Molecule Inhibitors (2011-Present)
Lv, Peng-Cheng
Sun, Juan
Zhu, Hai-Liang
CURRENT MEDICINAL CHEMISTRY, 2015, 22 (05) : 618 - 626
[43] Molecular simulation of the p53-MDM2 binding interface
Pantelopulos, George A.
Voelz, Vincent A.
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
[44] A dynamic p53-mdm2 model with distributed delay
Horhat, Raluca
Horhat, Raul Florin
10TH INTERNATIONAL CONFERENCE ON MATHEMATICAL PROBLEMS IN ENGINEERING, AEROSPACE AND SCIENCES (ICNPAA 2014), 2014, 1637 : 413 - 421
[45] Comparative study of the p53-mdm2 and p53-MDMX interfaces
Böttger, V
Böttger, A
Garcia-Echeverria, C
Ramos, YFM
van der Eb, AJ
Jochemsen, AG
Lane, DP
ONCOGENE, 1999, 18 (01) : 189 - 199
[46] A dynamic P53-MDM2 model with time delay
Mihalas, Gh. I.
Neamtu, M.
Opris, D.
Horhat, R. F.
CHAOS SOLITONS & FRACTALS, 2006, 30 (04) : 936 - 945
[47] Targeting the p53-MDM2 interaction to treat cancer
Klein, C
Vassilev, LT
BRITISH JOURNAL OF CANCER, 2004, 91 (08) : 1415 - 1419
[48] Tetra-substituted imidazoles as a new class of inhibitors of the p53-MDM2 interaction
Vaupel, Andrea
Bold, Guido
De Pover, Alain
Stachyra-Valat, Therese
Hergovich-Lisztwan, Joanna
Kallen, Joerg
Masuya, Keiichi
Furet, Pascal
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (09) : 2110 - 2114
[49] The p53-MDM2/MDMX axis - A chemotype perspective
Khoury, Kareem
Popowicz, Grzegorz M.
Holak, Tad A.
Doemling, Alexander
MEDCHEMCOMM, 2011, 2 (04) : 246 - 260
[50] Binding induced folding in p53-MDM2 complex
Chen, Hai-Feng
Luo, Ray
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2007, 129 (10) : 2930 - 2937

← 1 2 3 4 5 →